SCHEMBL23744809

SCHEMBL23744809

CP(C)c1cnc(N2CCN(C(=O)OC3CC4(C3)CN(Cc3ccccc3)C4)CC2)nc1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 6/20 0.42
ALDH1A1 P00352 4/20 0.42
HTR7 P34969 1/20 0.42
CYP3A4 P08684 5/20 0.41
CYP1A2 P05177 2/20 0.41
CYP2C9 P11712 2/20 0.41
CYP2C19 P33261 2/20 0.41
USP2 O75604 2/20 0.41
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM4 P08173 3/20 0.40
GHSR Q92847 1/20 0.39
TSHR P16473 3/20 0.39
MAPK1 P28482 1/20 0.38
OPRD1 P41143 1/20 0.37
OPRK1 P41145 1/20 0.37
F2 P00734 1/20 0.37
PRSS1 P07477 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23744120 0.91 CYP2D6 (0.45) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL24945761 0.90 HTR7 (0.44) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL24945665 0.88 MAPK1 (0.45) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL24944794 0.86 ALDH1A1 (0.40) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL26087084 0.86 CHRM2 (0.56) CYP2D6HTR7CYP3A4CYP1A2USP2
SCHEMBL26089375 0.86 CYP3A4 (0.46) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL24945637 0.85 CYP3A4 (0.41) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL24944734 0.84 CYP3A4 (0.40) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL23744790 0.83 CHRM2 (0.41) CYP2D6ALDH1A1HTR7CYP3A4CYP1A2
SCHEMBL30345522 0.78 CHRM2 (0.57) ALDH1A1CHRM2CHRM1CHRM4TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021158698-A1 MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE NEUROCRINE BIOSCIENCES, INC. (US) 2021-08-12 WO disclosed